Save for later

Diabetes UK responds to study on diabetes medication

Thumbnail

Diabetes UK has today responded to new research from UCL, the University of Michigan and the Ann Arbor Veterans Affairs Hospital that that suggests that some diabetes medications might be doing some people more harm than good.The study, published in JAMA Internal Medicine, found that whether patients with Type 2 diabetes, particularly older people, benefit from diabetes treatment depends less on their blood sugar level than their age and the side-effects of the treatment.Simon O’Neill, Director of Health Intelligence for Diabetes UK, said: “Clearly, everyone with Type 1 diabetes needs to have insulin to stay alive. But for the treatment of Type 2 diabetes, sometimes there is a balance to be struck where certain medications might help give someone a longer life but also cause side effects that might negatively impact on quality of life.“This study highlights the importance of looking at the individual needs of the person with Type 2 diabetes, rather than adopting a blanket approach. It also underlines how vital it is that healthcare professionals and people with diabetes work closely together to jointly decide what the best treatment options are for that person and weighing up the potential benefits and side-effects, which will vary from person-to-person, needs to be at the centre of that discussion.“This is why having a care plan jointly agreed by the person and the healthcare professional is part of the 15 Healthcare Essentials that everyone with the condition should get.“If anyone with diabetes is concerned about their own medication, they should discuss this with their GP. We would strongly advise people not to stop taking medication without talking to their GP first.”

E-newsletter

Brand Icons/Telephone check - FontAwesome icons/tick icons/uk